Literature DB >> 25960964

Rhabdomyolysis in the setting of induced hypothyroidism and statin therapy: a case report.

Yaser Jbara1, Dean Bricker1.   

Abstract

Mild elevation of creatine kinase (CK) is common in untreated hypothyroidism, but severe myositis and overt rhabdomyolysis are rare. Similarly, muscle pain and CK elevation are potential side effects of statin therapy, yet rhabdomyolysis is likewise rare in the absence of medication interactions adversely affecting statin metabolism. The coexistence of statin therapy and hypothyroid states may synergistically increase the risk of myopathy. We describe a case of rhabdomyolysis attributable to induced hypothyroidism in a patient on chronic statin medication who was anticipating adjuvant radioiodine ((131)I) therapy for a thyroid carcinoma.

Entities:  

Keywords:  Induced hypothyroidism; Recombinant human thyrotropin; Rhabdomyolysis; Statin therapy

Year:  2015        PMID: 25960964      PMCID: PMC4404889          DOI: 10.1159/000371548

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  15 in total

Review 1.  Safety of statins: focus on clinical pharmacokinetics and drug interactions.

Authors:  Stefano Bellosta; Rodolfo Paoletti; Alberto Corsini
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

2.  A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.

Authors:  Pamela R Schroeder; Bryan R Haugen; Furio Pacini; Christoph Reiners; Martin Schlumberger; Steven I Sherman; David S Cooper; Kathryn G Schuff; Lewis E Braverman; Monica C Skarulis; Terry F Davies; Ernest L Mazzaferri; Gilbert H Daniels; Douglas S Ross; Markus Luster; Mary H Samuels; Bruce D Weintraub; E Chester Ridgway; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2006-01-04       Impact factor: 5.958

3.  Mechanisms of statin-induced myopathy: a role for the ubiquitin-proteasome pathway?

Authors:  M John Chapman; Alain Carrie
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12       Impact factor: 8.311

4.  HMG-CoA reductase inhibitors (statins) might cause high elevations of creatine phosphokinase (CK) in patients with unnoticed hypothyroidism.

Authors:  Kotaro Tokinaga; Toru Oeda; Yoshifumi Suzuki; Yasuhisa Matsushima
Journal:  Endocr J       Date:  2006-05-25       Impact factor: 2.349

Review 5.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

6.  Correlation between severity of thyroid dysfunction and renal function.

Authors:  Jan G den Hollander; Remi W Wulkan; Mart J Mantel; Arie Berghout
Journal:  Clin Endocrinol (Oxf)       Date:  2005-04       Impact factor: 3.478

7.  Hypothyroidism-induced rhabdomyolysis and renal failure.

Authors:  Mohammad Reza Ardalan; Kamyar Ghabili; Reshad Mirnour; Mohammadali M Shoja
Journal:  Ren Fail       Date:  2011-04-18       Impact factor: 2.606

8.  Two cases of statin-induced myopathy caused by induced hypothyroidism.

Authors:  Howard M Lando; Kenneth D Burman
Journal:  Endocr Pract       Date:  2008-09       Impact factor: 3.443

9.  Pravastatin-associated myopathy. Report of a case.

Authors:  T Scalvini; D Marocolo; B Cerudelli; I Sleiman; G P Balestrieri; G Giustina
Journal:  Recenti Prog Med       Date:  1995-05

10.  Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke.

Authors:  Tatjana Rundek; Ali Naini; Ralph Sacco; Kristen Coates; Salvatore DiMauro
Journal:  Arch Neurol       Date:  2004-06
View more
  2 in total

Review 1.  Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature.

Authors:  Alessandro Sindoni; Carmelo Rodolico; Maria Angela Pappalardo; Simona Portaro; Salvatore Benvenga
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

2.  Rhabdomyolysis in a Patient with Severe Hypothyroidism.

Authors:  Nooshin Salehi; Endre Agoston; Iqbal Munir; Gary J Thompson
Journal:  Am J Case Rep       Date:  2017-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.